Text Size

One-year results on the safety and efficacy of the InnFocus MicroShunt depending on placement and concentration of mitomycin C [Résultats à un an de l’efficacité et de l’innocuité du MicroShunt InnFocus selon l’emplacement et la concentration de MMC]

Riss I., Batlle J., Pinchuk L., Kato Y.P., Weber B.A., Parel J.-M.


  • 2015
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Pôle Ophtalmologique, Clinique Mutualiste, 46/54, avenue du Dr-Albert-Schweitzer, Pessac, 33600, France; Centro Laser, Santo Domingo, Calle Padre Fantino Falco 3, Santo Domingo, Dominica; InnFocus Inc., 12415 SW 136th Avenue #3, Miami, FL 33186, United States; Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller, 900 NW 17th Street, Miami, FL 33136, United States

Related Publications

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.


Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

Yamamura K.; Mano H.; Fuwa M.; Ryoiwamura; Odani-Kawabata N.


Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022